The analysis, which has yet to be confirmed, found that Abbott’s ID NOW missed at least one-third of positive cases detected with a rival test and much as 48% when using the currently recommended dry nasal swabs, according to the report posted on BioRxiv, a server where researchers post early work before it has been reviewed by other scientists.
See the report here:
https://www.biorxiv.org/content/10.1101/2020.05.11.089896v1?rss=1
TITLE:
Performance of the rapid Nucleic Acid Amplification by Abbott ID NOW COVID-19 in nasopharyngeal swabs transported in viral media and dry nasal swabs, in a New York City academic institution
However, BioRvix always posts this caveat on their website:
bioRxiv is receiving many new papers on coronavirus SARS-CoV-2. A reminder: these are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information.
The only solution is to find test kits made by a company President Trump has not praised.
Sounds like a marketing ploy to resurrect sales of the chicom tests containing the pre-virus loaded nasal swabs.
yup. was given an early heads up on this specific test from my lab contacts. i can support this report. hope Abbott comes clean and fixes it, for all our sakes.